Global Influenza Diagnostics Market By Test Type (Traditional Diagnostics Tests and Molecular Diagnostic Tests); By End-User (Hospitals, Clinical Laboratories, Research Centers, Point of Care Testing Centers and Other End User); By Type of Flu (Type A, Type B and Type C); and Region – Analysis of Market Size, Share & Trends for 2018 – 2020 and Forecasts to 2030
Global Influenza Diagnostics Market By Test Type (Traditional Diagnostics Tests and Molecular Diagnostic Tests); By End-User (Hospitals, Clinical Laboratories, Research Centers, Point of Care Testing Centers and Other End User); By Type of Flu (Type A, Type B and Type C); and Region – Analysis of Market Size, Share & Trends for 2018 – 2020 and Forecasts to 2030
1. EXECUTIVE SUMMARY
2. INFLUENZA DIAGNOSTICS
2.1. Influenza Diagnostics Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MARKET DYNAMICS
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
7. RISK ANALYSIS
7.1. Demand Risk Analysis
7.2. Supply Risk Analysis
8. INFLUENZA DIAGNOSTICS INDUSTRY ANALYSIS
8.1. Porters Five Forces
8.1.1. The threat of New Entrants
8.1.2. Bargaining Power of Suppliers
8.1.3. Threat of Substitutes
8.1.4. Rivalry
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. GLOBAL INFLUENZA DIAGNOSTICS MARKET
9.1. Market Size & forecast, 2019A-2030F
9.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
9.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10. GLOBAL INFLUENZA DIAGNOSTICS MARKET: MARKET SEGMENTATION
10.1. By Regions
10.1.1. North America: (U.S. and Canada)
10.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
10.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
10.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
10.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.5. The Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
10.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2. By Test Type: Market Share (2020-2030F)
10.2.1. Traditional Diagnostics Tests, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.2. Molecular Diagnostic Tests, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3. By Type of Flu: Market Share (2020-2030F)
10.3.1. Type A, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.2. Type B, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.3. Type C, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4. By End User: Market Share (2020-2030F)
10.4.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.2. Clinical Laboratories, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.3. Research Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.4. Point of Care Testing Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.5. Other End User, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. COMPANY PROFILE
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Company Total Revenue (Financials)
11.1.3. Market Potential
11.1.4. Global Presence
11.1.5. Key Performance Indicators
11.1.6. SWOT Analysis
11.1.7. Product Launch
11.2. Siemens Healthineers
11.3. Analytik Jena
11.4. Quidel Corporation
11.5. Genome Diagnostics
11.6. Meridian Bioscience
11.7. BioMerieux SA
11.8. Sekisui Diagnostics
11.9. Response Biomedical
11.10. SA Scientific
11.11. Enigma Diagnostics
11.12. Focus Diagnostics
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. INFLUENZA DIAGNOSTICS
2.1. Influenza Diagnostics Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MARKET DYNAMICS
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
7. RISK ANALYSIS
7.1. Demand Risk Analysis
7.2. Supply Risk Analysis
8. INFLUENZA DIAGNOSTICS INDUSTRY ANALYSIS
8.1. Porters Five Forces
8.1.1. The threat of New Entrants
8.1.2. Bargaining Power of Suppliers
8.1.3. Threat of Substitutes
8.1.4. Rivalry
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. GLOBAL INFLUENZA DIAGNOSTICS MARKET
9.1. Market Size & forecast, 2019A-2030F
9.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
9.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10. GLOBAL INFLUENZA DIAGNOSTICS MARKET: MARKET SEGMENTATION
10.1. By Regions
10.1.1. North America: (U.S. and Canada)
10.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
10.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
10.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
10.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.5. The Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
10.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2. By Test Type: Market Share (2020-2030F)
10.2.1. Traditional Diagnostics Tests, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.2. Molecular Diagnostic Tests, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3. By Type of Flu: Market Share (2020-2030F)
10.3.1. Type A, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.2. Type B, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.3. Type C, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4. By End User: Market Share (2020-2030F)
10.4.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.2. Clinical Laboratories, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.3. Research Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.4. Point of Care Testing Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.5. Other End User, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. COMPANY PROFILE
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Company Total Revenue (Financials)
11.1.3. Market Potential
11.1.4. Global Presence
11.1.5. Key Performance Indicators
11.1.6. SWOT Analysis
11.1.7. Product Launch
11.2. Siemens Healthineers
11.3. Analytik Jena
11.4. Quidel Corporation
11.5. Genome Diagnostics
11.6. Meridian Bioscience
11.7. BioMerieux SA
11.8. Sekisui Diagnostics
11.9. Response Biomedical
11.10. SA Scientific
11.11. Enigma Diagnostics
11.12. Focus Diagnostics
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.